We measured the transcriptional activity of both AhR canonical and non-canonical in melanoma cell lines from the “Cancer Cell Line Encyclopedia” (CCLE)29, using representative 14 and 19 genes of the β- and α-signatures, respectively, and 16 genes from the BRAFi-resistance signature13–16,25,30. The gene discussed is AHR; the disease is melanoma.